DJIA 16,540.45 -102.56 -0.62%
NASDAQ 4,803.92 -24.41 -0.51%
S&P 500 1,976.16 -12.71 -0.64%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

54.00 -1.37 (-2.47%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $53.98 -2.51%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.12
Previous Close $55.37
Daily Range $53.75 - $55.30
52-Week Range $45.69 - $63.62
Market Cap $152.1B
P/E Ratio 16.33
Dividend (Yield) $1.80 (3.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,227,843
Average Daily Volume 11,123,400
Current FY EPS $3.51




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Are DPP-4 inhibitors like Januvia on their way out? A new long-term study from partners Eli Lilly and Boehringer Ingelheim suggests it's a possibility.

CELG, PFE, REGN, RCPT Jim Cramer's Views

An 80/20 Filter On How The DJIA Weathered The Week

The Zacks Analyst Blog Highlights: Merck & Co, Apple, Visa, Microsoft and Intel

Novo Nordisk to Start PIONEER Program on Semaglutide

5 Stocks That Led Dow to 3rd Biggest Gain

JNJ’s Splenda Sale Shouldn’t Be A Concern For Investors

Eli Lilly's Diabetes Drug May Halt Heart Disease

Eli Lilly's Jardiance was shown to reduce the risk of heart attack and stroke in diabetics.

The 4 Stocks That Boosted the DJIA on Wednesday

Trade-Ideas: Merck (MRK) Is Today's "Dead Cat Bounce" Stock

See More MRK News...

MRK's Top Competitors

MRK $54.00 (-2.47%)
Current stock: MRK
JNJ $94.53 (-0.67%)
Current stock: JNJ
NVS $97.73 (-0.63%)
Current stock: NVS
RHHBY $34.04 (-0.35%)
Current stock: RHHBY